Wolchok JD - Search Results

1

Prophylactic recombinant epoetin alfa markedly reduces the need for blood transfusion in patients with metastatic melanoma treated with biochemotherapy.

Wolchok JD, Klimek VM, Williams L, Chapman PB. Wolchok JD, et al. Cytokines Cell Mol Ther. 1999 Dec;5(4):205-6. Cytokines Cell Mol Ther. 1999. PMID: 10850383

2

Injection of DNA encoding granulocyte-macrophage colony-stimulating factor recruits dendritic cells for immune adjuvant effects.

Bowne WB, Wolchok JD, Hawkins WG, Srinivasan R, Gregor P, Blachere NE, Moroi Y, Engelhorn ME, Houghton AN, Lewis JJ. Bowne WB, et al. Among authors: wolchok jd. Cytokines Cell Mol Ther. 1999 Dec;5(4):217-25. Cytokines Cell Mol Ther. 1999. PMID: 10850386

3

Systemic chemotherapy.

Klimek VM, Wolchok JD, Chapman PB, Houghton AN, Hwu WJ. Klimek VM, et al. Among authors: wolchok jd. Clin Plast Surg. 2000 Jul;27(3):451-61, ix-x. Clin Plast Surg. 2000. PMID: 10941565 Review.

4

Phase I trial of adoptive immunotherapy with cytolytic T lymphocytes immunized against a tyrosinase epitope.

Wolchok JD, Chapman PB. Wolchok JD, et al. J Clin Oncol. 2002 Jul 15;20(14):3176; author reply 3176-7. doi: 10.1200/JCO.2002.20.14.3176. J Clin Oncol. 2002. PMID: 12118032 No abstract available.

5

Clinical results using biochemotherapy as a standard of care in advanced melanoma.

Chapman PB, Panageas KS, Williams L, Wolchok JD, Livingston PO, Quinn C, Hwu WJ. Chapman PB, et al. Among authors: wolchok jd. Melanoma Res. 2002 Aug;12(4):381-7. doi: 10.1097/00008390-200208000-00011. Melanoma Res. 2002. PMID: 12170188

6

How can we tell when cancer vaccines vaccinate?

Wolchok JD, Chapman PB. Wolchok JD, et al. J Clin Oncol. 2003 Feb 15;21(4):586-7. doi: 10.1200/JCO.2003.12.065. J Clin Oncol. 2003. PMID: 12586792 No abstract available.

7

Phase I trial of high dose paracetamol and carmustine in patients with metastatic melanoma.

Wolchok JD, Williams L, Pinto JT, Fleisher M, Krown SE, Hwu WJ, Livingston PO, Chang C, Chapman PB. Wolchok JD, et al. Melanoma Res. 2003 Apr;13(2):189-96. doi: 10.1097/00008390-200304000-00013. Melanoma Res. 2003. PMID: 12690304 Clinical Trial.

8

GM-CSF DNA induces specific patterns of cytokines and chemokines in the skin: implications for DNA vaccines.

Perales MA, Fantuzzi G, Goldberg SM, Turk MJ, Mortazavi F, Busam K, Houghton AN, Dinarello CA, Wolchok JD. Perales MA, et al. Among authors: wolchok jd. Cytokines Cell Mol Ther. 2002;7(3):125-33. doi: 10.1080/13684730310000923. Cytokines Cell Mol Ther. 2002. PMID: 12850812

9

Phase II study of temozolomide plus thalidomide for the treatment of metastatic melanoma.

Hwu WJ, Krown SE, Menell JH, Panageas KS, Merrell J, Lamb LA, Williams LJ, Quinn CJ, Foster T, Chapman PB, Livingston PO, Wolchok JD, Houghton AN. Hwu WJ, et al. Among authors: wolchok jd. J Clin Oncol. 2003 Sep 1;21(17):3351-6. doi: 10.1200/JCO.2003.02.061. J Clin Oncol. 2003. PMID: 12947072 Clinical Trial.

10

Consistent antibody response against ganglioside GD2 induced in patients with melanoma by a GD2 lactone-keyhole limpet hemocyanin conjugate vaccine plus immunological adjuvant QS-21.

Ragupathi G, Livingston PO, Hood C, Gathuru J, Krown SE, Chapman PB, Wolchok JD, Williams LJ, Oldfield RC, Hwu WJ. Ragupathi G, et al. Among authors: wolchok jd. Clin Cancer Res. 2003 Nov 1;9(14):5214-20. Clin Cancer Res. 2003. PMID: 14614001

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

480 results

Search Page

Filters